EMEA-002312-PIP01-17-M01
Key facts
Active substance |
Abrocitinib
|
Therapeutic area |
Dermatology
|
Decision number |
P/0023/2020
|
PIP number |
EMEA-002312-PIP01-17-M01
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of atopic dermatitis
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Pfizer Europe MA EEIG
Tel. +44 1304 6466 07 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|